Literature DB >> 34553800

Face atopic dermatitis resistant to dupilumab: a case series of three patients successfully treated with upadacitinib.

G Licata1, A Gambardella1, V Tancredi1, G Calabrese1, A De Rosa1, R Alfano2, G Argenziano1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34553800     DOI： 10.1111/jdv.17705

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  1 in total

1.  Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort Study.

Authors:  Ketty Peris; Antonio Costanzo; Andrea Chiricozzi; Niccolò Gori; Alessandra Narcisi; Anna Balato; Alessio Gambardella; Michela Ortoncelli; Angelo Valerio Marzano; Riccardo Balestri; Giovanni Palazzo; Michele Pellegrino; Marco Romanelli; Giovanni Tripepi
Journal:  Drugs R D       Date:  2022-08-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.